RVF and Other Emerging Infectious Diseases in East and Central Africa
Studying Coccidioidomycosis
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Washington State University
- Principal Investigator
- M. Kariuki Njenga, PhDWashington State University
- Intervention
- Evidence of past or recent RVF exposure(other)
- Enrollment
- 5000 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2021 – 2025
Study locations (10)
- Virunga Hospital & North Kivu, Goma, North Kivu, Democratic Republic of the Congo
- South Kivu, Bukavu, Democratic Republic of the Congo
- Tana River County, Hola, Kenya
- Isiolo county, Isiolo, Kenya
- Marsabit county, Marsabit, Kenya
- Muranga county, Murang’a, Kenya
- Iringa, Iringa, Tanzania
- Rwekubbo health centre IV & Isingiro district, Isingiro, Uganda
- Kabale Regional Referral Hospital & Kabale district, Kabale, Uganda
- Rwekubo Health Centre IV & Rubanda district, Rubanda, Uganda
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID) · Emory University · Washington University School of Medicine · Kenya Medical Research Institute · University of Nairobi · The International Livestock Research Institute (ILRI) · MRC/UVRI and LSHTM Uganda Research Unit · Sokoine University of Agriculture · Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo · Institute of Tropical Medicine, Belgium · Charite University, Berlin, Germany · Kenya Ministry of Health · Ministry of Agriculture Livestock Fisheries and Cooperatives, Kenya · Ministry of Agriculture, Animal Industry and Fisheries, Uganda · Ministry of Health, Uganda · Ministry of Public Health, Democratic Republic of the Congo · Ministry of Agriculture, Fisheries and Livestock, Democratic Republic of Congo
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05139524 on ClinicalTrials.govOther trials for Coccidioidomycosis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT06799234Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)University of Oxford
- ACTIVE NOT RECRUITINGPHASE1NCT06925919Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011IDBiologics, Inc.
- ACTIVE NOT RECRUITINGNANCT06913803To Find Effectiveness of Stretching Versus Soft Tissue Mobilization in Coccydynia in Postpartum FemalesSuperior University
- RECRUITINGPHASE2NCT03609398Phase 2 Safety and Immunogenicity Study of Rift Valley Fever VaccineU.S. Army Medical Research and Development Command
- RECRUITINGNCT02190266Pathogenesis and Genetics of Disseminated or Refractory CoccidioidomycosisNational Institute of Allergy and Infectious Diseases (NIAID)